Cargando…

SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation

Background: While diabetes mellitus from growth hormone related insulin resistance is not uncommon in GH secreting tumors, initial presentation with diabetic ketoacidosis is rare. Clinical Case: 31 YO male with no significant past medical history presented with c/o fatigue, 40 lb weight loss, polyur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundluru, Rajani, Verma, Ritika, Regunath, Hariharan, Gardner, Michael J, Huynh, Kiet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207508/
http://dx.doi.org/10.1210/jendso/bvaa046.1077
_version_ 1783530621792944128
author Gundluru, Rajani
Verma, Ritika
Regunath, Hariharan
Gardner, Michael J
Huynh, Kiet
author_facet Gundluru, Rajani
Verma, Ritika
Regunath, Hariharan
Gardner, Michael J
Huynh, Kiet
author_sort Gundluru, Rajani
collection PubMed
description Background: While diabetes mellitus from growth hormone related insulin resistance is not uncommon in GH secreting tumors, initial presentation with diabetic ketoacidosis is rare. Clinical Case: 31 YO male with no significant past medical history presented with c/o fatigue, 40 lb weight loss, polyuria, polydipsia. Clinical features of acromegaly with frontal bossing, protruding jaw, large hands and feet, thick spade like fingers, hammer toes, high arches and thickened fat pads on both feet were noted. Initial labs were consistent with DKA with anion of 31 mmol/L (0-20), blood glucose 241 mg/dl, bicarb 12 mmol/L (22-29), serum betahydroxy butyrate > 8 mmol/L (0-0.29), urine positive for glucose, ketones, protein. Patient was initially treated with IV insulin per DKA protocol, transitioned to subcutaneous insulin. MRI brain showed 2.1x1.3x2.1 cm pituitary macro adenoma. Labs showed elevated IGF1 LC/MS, S 1094 ng/ml (54-310), IGFBP3 14 mcg/ml (3.5-7), Z score IGF MS Mayo > 3 (-2 to +2), normal FSH 7.1 m unit/ml (1.5-12.4), normal LH 3.4 m unit/ml (1.7-8.6), normal prolactin 6 ng/ml (4-15), normal ACTH 10 pg/ml, cortisol 13.4 mcg/dl, low total testosterone 48.2 ng/dl (193-836), normal free testosterone 7.92 ng/dl (4.85-19), normal TSH 1.55 mc unit/ml (0.27-4.2) and free T4 1.17 ng/dl (0.93-1.7). The patient was discharged home on 120+ units of total daily dose of insulin, after initial hospital admission. He underwent trans sphenoidal resection of pituitary macro adenoma one month after his initial presentation. Surgical pathology confirmed growth hormone producing adenoma. He was successfully weaned off from insulin in one month following surgery. Conclusion: DKA is an unusual initial presentation of growth hormone producing tumors. As more cases are being reported it is important to be vigilant to look for DKA presentation in these patients and adjust/wean patients insulin once the growth hormone producing tumor is treated either with surgery or medications.
format Online
Article
Text
id pubmed-7207508
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72075082020-05-13 SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation Gundluru, Rajani Verma, Ritika Regunath, Hariharan Gardner, Michael J Huynh, Kiet J Endocr Soc Neuroendocrinology and Pituitary Background: While diabetes mellitus from growth hormone related insulin resistance is not uncommon in GH secreting tumors, initial presentation with diabetic ketoacidosis is rare. Clinical Case: 31 YO male with no significant past medical history presented with c/o fatigue, 40 lb weight loss, polyuria, polydipsia. Clinical features of acromegaly with frontal bossing, protruding jaw, large hands and feet, thick spade like fingers, hammer toes, high arches and thickened fat pads on both feet were noted. Initial labs were consistent with DKA with anion of 31 mmol/L (0-20), blood glucose 241 mg/dl, bicarb 12 mmol/L (22-29), serum betahydroxy butyrate > 8 mmol/L (0-0.29), urine positive for glucose, ketones, protein. Patient was initially treated with IV insulin per DKA protocol, transitioned to subcutaneous insulin. MRI brain showed 2.1x1.3x2.1 cm pituitary macro adenoma. Labs showed elevated IGF1 LC/MS, S 1094 ng/ml (54-310), IGFBP3 14 mcg/ml (3.5-7), Z score IGF MS Mayo > 3 (-2 to +2), normal FSH 7.1 m unit/ml (1.5-12.4), normal LH 3.4 m unit/ml (1.7-8.6), normal prolactin 6 ng/ml (4-15), normal ACTH 10 pg/ml, cortisol 13.4 mcg/dl, low total testosterone 48.2 ng/dl (193-836), normal free testosterone 7.92 ng/dl (4.85-19), normal TSH 1.55 mc unit/ml (0.27-4.2) and free T4 1.17 ng/dl (0.93-1.7). The patient was discharged home on 120+ units of total daily dose of insulin, after initial hospital admission. He underwent trans sphenoidal resection of pituitary macro adenoma one month after his initial presentation. Surgical pathology confirmed growth hormone producing adenoma. He was successfully weaned off from insulin in one month following surgery. Conclusion: DKA is an unusual initial presentation of growth hormone producing tumors. As more cases are being reported it is important to be vigilant to look for DKA presentation in these patients and adjust/wean patients insulin once the growth hormone producing tumor is treated either with surgery or medications. Oxford University Press 2020-05-08 /pmc/articles/PMC7207508/ http://dx.doi.org/10.1210/jendso/bvaa046.1077 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Gundluru, Rajani
Verma, Ritika
Regunath, Hariharan
Gardner, Michael J
Huynh, Kiet
SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
title SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
title_full SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
title_fullStr SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
title_full_unstemmed SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
title_short SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
title_sort sat-251 new diagnosis of acromegaly with dka as initial presentation
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207508/
http://dx.doi.org/10.1210/jendso/bvaa046.1077
work_keys_str_mv AT gundlururajani sat251newdiagnosisofacromegalywithdkaasinitialpresentation
AT vermaritika sat251newdiagnosisofacromegalywithdkaasinitialpresentation
AT regunathhariharan sat251newdiagnosisofacromegalywithdkaasinitialpresentation
AT gardnermichaelj sat251newdiagnosisofacromegalywithdkaasinitialpresentation
AT huynhkiet sat251newdiagnosisofacromegalywithdkaasinitialpresentation